ARTICLE | Clinical News
Allogeneic iMP cells: Phase II data
July 13, 2015 7:00 AM UTC
The Phase II HeartCel trial in advanced heart failure patients at high risk of incomplete revascularization with coronary artery bypass graft (CABG) surgery showed that allogeneic iMP cells injected ...